Arsonnaud S - Search Results

1

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.

Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, Kang S. Thiboutot DM, et al. Among authors: arsonnaud s. Arch Dermatol. 2006 May;142(5):597-602. doi: 10.1001/archderm.142.5.597. Arch Dermatol. 2006. PMID: 16702497 Clinical Trial.

2

Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.

Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S; Differin Study Group. Thiboutot DM, et al. Among authors: arsonnaud s. Skinmed. 2005 May-Jun;4(3):138-46. doi: 10.1111/j.1540-9740.2005.04279.x. Skinmed. 2005. PMID: 15891249 Free article. Clinical Trial.

3

Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.

Thiboutot D, Arsonnaud S, Soto P. Thiboutot D, et al. Among authors: arsonnaud s. J Drugs Dermatol. 2008 Jun;7(6 Suppl):s3-10. J Drugs Dermatol. 2008. PMID: 18575220 Clinical Trial.

4

Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.

Wolf JE Jr, Kerrouche N, Arsonnaud S. Wolf JE Jr, et al. Among authors: arsonnaud s. Cutis. 2006 Apr;77(4 Suppl):3-11. Cutis. 2006. PMID: 16706244 Clinical Trial.

5

Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.

Dosik JS, Arsonnaud S. Dosik JS, et al. Among authors: arsonnaud s. J Drugs Dermatol. 2007 Jun;6(6):632-8. J Drugs Dermatol. 2007. PMID: 17668529 Clinical Trial.

6

Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%.

Dosik JS, Homer K, Arsonnaud S. Dosik JS, et al. Among authors: arsonnaud s. Cutis. 2005 Apr;75(4):238-43. Cutis. 2005. PMID: 15916222 Clinical Trial.

7

Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.

Dosik JS, Homer K, Arsonnaud S. Dosik JS, et al. Among authors: arsonnaud s. Cutis. 2005 May;75(5):289-93. Cutis. 2005. PMID: 15984630 Clinical Trial.

8

A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.

Griffiths CE, Finlay AY, Fleming CJ, Barker JN, Mizzi F, Arsonnaud S. Griffiths CE, et al. Among authors: arsonnaud s. J Dermatolog Treat. 2006;17(2):90-5. doi: 10.1080/09546630500515701. J Dermatolog Treat. 2006. PMID: 16766333 Free article. Clinical Trial.

9

Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.

Dosik JS, Gilbert RD, Arsonnaud S. Dosik JS, et al. Among authors: arsonnaud s. Skinmed. 2006 Sep-Oct;5(5):219-23. doi: 10.1111/j.1540-9740.2006.04278.x. Skinmed. 2006. PMID: 16957432 Clinical Trial.

10

The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.

Queille-Roussel C, Duteil L, Parneix-Spake A, Arsonnaud S, Rizova E. Queille-Roussel C, et al. Among authors: arsonnaud s. Eur J Dermatol. 2001 May-Jun;11(3):219-24. Eur J Dermatol. 2001. PMID: 11358728 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters